Show notes
In this episode of Medsider Radio, we had an insightful discussion with Dr. Eric Fain, CEO and President of Procyrion — a startup developing an advanced percutaneous mechanical circulatory support device for patients with chronic heart failure. Eric began his career at Ventritex, a startup focused on implantable defibrillators. Over the next 30 years, and through the company’s acquisition by St. Jude Medical, he has held a number of leadership roles overseeing global sales, marketing, R&D, and clinical, eventually becoming the Group President via St. Jude’s exit to Abbott. In this interview, Eric shares his expertise in managing startup finances, attracting investors through strategic planning, drawing up clear clinical roadmaps, and engaging with payers to catalyze commercialization. Before we dive into the discussion, I wanted to mention a few things:First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume V. If you’re interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Dr. Eric Fain.